demonstrated an attenuation of Parkinsonism in MPTP-treated mice with a NOPr antagonist, and a synergistic effect when this was employed with L-DOPA, indicating that the NOPr system was exerting its effects via dopamine transmission (also supported by Marti et al.29)28,31. The gene discussed is OPRL1; the disease is Parkinsonism.